Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience.

Autor: Peña Pino I; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA., Ma J; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA., Hori YS; Department of Neurosurgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Fomchenko E; Department of Neurosurgery, Yale University School of Medicine, and Yale Cancer Center, New Haven, CT, USA., Dusenbery K; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA., Reynolds M; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA., Wilke C; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA., Yuan J; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA., Srinivasan E; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Grabowski M; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Fecci P; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Domingo-Musibay E; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Fujioka N; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Barnett GH; Department of Neurosurgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Chang V; Department of Neurosurgery, Yale University School of Medicine, and Yale Cancer Center, New Haven, CT, USA., Mohammadi AM; Department of Neurosurgery, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Chen CC; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA. ccchen@umn.edu.; Department of Neurosurgery, University of Minnesota Medical School, D429 Mayo Memorial Building, 420 Delaware St. S. E., MMC96, Minneapolis, MN, 55455, USA. ccchen@umn.edu.
Jazyk: angličtina
Zdroj: Journal of neuro-oncology [J Neurooncol] 2022 Jan; Vol. 156 (2), pp. 295-306. Date of Electronic Publication: 2022 Jan 10.
DOI: 10.1007/s11060-021-03893-6
Abstrakt: Introduction: The optimal treatment paradigm for brain metastasis that recurs locally after initial radiosurgery remains an area of active investigation. Here, we report outcomes for patients with BMRS treated with stereotactic laser ablation (SLA, also known as laser interstitial thermal therapy, LITT) followed by consolidation radiosurgery.
Methods: Clinical outcomes of 20 patients with 21 histologically confirmed BMRS treated with SLA followed by consolidation SRS and > 6 months follow-up were collected retrospectively across three participating institutions.
Results: Consolidation SRS (5 Gy × 5 or 6 Gy × 5) was carried out 16-73 days (median of 26 days) post-SLA in patients with BMRS. There were no new neurological deficits after SLA/cSRS. While 3/21 (14.3%) patients suffered temporary Karnofsky Performance Score (KPS) decline after SLA, no KPS decline was observed after cSRS. There were no 30-day mortalities or wound complications. Two patients required re-admission within 30 days of cSRS (severe headache that resolved with steroid therapy (n = 1) and new onset seizure (n = 1)). With a median follow-up of 228 days (range: 178-1367 days), the local control rate at 6 and 12 months (LC 6 , LC 12 ) was 100%. All showed diminished FLAIR volume surrounding the SLA/cSRS treated BMRS at the six-month follow-up; none of the patients required steroid for symptoms attributable to these BMRS. These results compare favorably to the available literature for repeat SRS or SLA-only treatment of BMRS.
Conclusions: This multi-institutional experience supports further investigations of SLA/cSRS as a treatment strategy for BMRS.
(© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: